Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BNTX
BNTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BNTX News
Analysis of Investment Prospects in Healthcare Stocks
5d ago
Fool
BioNTech Reports Phase 2 Results for HER2 Cancer Drug
Apr 13 2026
NASDAQ.COM
Trastuzumab Pamirtecan Shows Promising Results in Endometrial Cancer Clinical Trial
Apr 11 2026
Newsfilter
BioNTech's Trastuzumab Pamirtecan Shows Promising Results in Endometrial Cancer Trial
Apr 11 2026
Yahoo Finance
BOEHRINGER INGELHEIM: BIONTECH AND CO MAINTAIN COMPLETE OWNERSHIP OF THEIR ASSETS, WITH A NON-EXCLUSIVE MUTUAL AGREEMENT
Apr 09 2026
moomoo
Boehringer Ingelheim: BioNTech to Provide Pumitamig, While Co. Acts as Regulatory Sponsor for Phase IB/II Trial
Apr 09 2026
moomoo
Pfizer and BioNTech Halt COVID Vaccine Trial Recruitment
Apr 01 2026
seekingalpha
Belgian Court Orders Poland and Romania to Accept Vaccine Delivery
Apr 01 2026
seekingalpha
mRNA Vaccine Stocks Rise as HHS Committee Revises Recommendations
Mar 11 2026
seekingalpha
Serve Robotics Shares Surge After Strong Q4 Results and Upgraded Sales Guidance
Mar 11 2026
Benzinga
BioNTech Q4 2025 Earnings Call Insights
Mar 10 2026
seekingalpha
BioNTech Stock Plummets Amid Revenue Concerns
Mar 10 2026
Benzinga
BioNTech's Disappointing Guidance Leads to Share Price Plunge
Mar 10 2026
Fool
Hims & Hers Shares Rise, BioNTech Crashes Amid Leadership Changes
Mar 10 2026
CNBC
U.S. Stocks Mixed in Morning Trading
Mar 10 2026
Benzinga
BioNTech's Strategic Shift and Clinical Progress
Mar 10 2026
Benzinga
Show More News
